SEK14.55 0.4 2.8%
Last Trade - 5:00pm
| Market Cap | £19.1m |
| Enterprise Value | £14.6m |
| Revenue | £998k |
| Position in Universe | 1392nd / 1857 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Dec | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 3.60 | 3.76 | 4.67 | 6.71 | 9.27 | 11.7 | 96.0 | 178 | +26.5% | ||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Bioservo Technologies AB is a Sweden-based company within wearable technologies based on bionic soft robotics. It is engaged in developing, producing and selling muscle strengthening equipment based on the patented SEM Technology (Soft Extra Muscle Technology). The technology implies so called intention detection logic that activates the support if the wearer initiates movement with a natural and intuitive movement. This is achieved by sensors that detect the user’s action and strengthens this action by activating the motors. Its main product is a SEM Glove. The products are designed for people that have an impaired grip strength caused by injured nerves, weakening in the muscles or pain in the muscles/muscular attachments. The product is applicable in the healthcare and industry sectors.
| Last Annual | December 31st, 2020 |
| Last Interim | December 31st, 2020 |
| Public Since | May 22, 2017 |
| No. of Shareholders: | n/a |
| No. of Employees: | 28 |
| Sector | Healthcare |
| Industry | Healthcare Equipment & Supplies |
| Index | |
| Exchange | OMX Nordic Exchange Stockholm |
| Shares in Issue | 15,798,321 |
| Free Float | (0.0%) |
| Eligible for |
ISAs
SIPPs
|
| Address | Torshamnsgatan 35, KISTA, 164 40, Sweden |
| Web | https://www.bioservo.com/ |
| Phone | +46 8 211710 |
| Contact | () |
| Auditors | MAZARS |
As of 5:00pm, shares in Bioservo Technologies AB are trading at SEK14.55, giving the company a market capitalisation of £19.1m. This share price information is delayed by 15 minutes.
Shares in Bioservo Technologies AB are currently trading at SEK14.55 and the price has moved by 5.6% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Bioservo Technologies AB price has moved by -1.05% over the past year.
There are no analysts currently covering Bioservo Technologies AB.
Bioservo Technologies AB is scheduled to issue upcoming financial results on the following dates:
Bioservo Technologies AB does not currently pay a dividend.
Bioservo Technologies AB does not currently pay a dividend.
Bioservo Technologies AB does not currently pay a dividend.
To buy shares in Bioservo Technologies AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Bioservo Technologies AB are currently trading at SEK14.55, giving the company a market capitalisation of £19.1m.
Here are the trading details for Bioservo Technologies AB:
Based on an overall assessment of its quality, value and momentum, Bioservo Technologies AB is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Shares in Bioservo Technologies AB are currently priced at SEK14.55. At that level they are trading at 72.01% discount to the analyst consensus target price of 0.00.
Analysts covering Bioservo Technologies AB currently have a consensus Earnings Per Share (EPS) forecast of 0.2 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Bioservo Technologies AB. Over the past six months, the relative strength of its shares against the market has been 2.52%. At the current price of SEK14.55, shares in Bioservo Technologies AB are trading at 10.52% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We were not able to find PE ratio data for Bioservo Technologies AB.
Bioservo Technologies AB's management team is headed by:
Here are the top five shareholders of Bioservo Technologies AB based on the size of their shareholding:
